Literature DB >> 19769962

ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity.

Dorte Stautz1, Archana Sanjay, Matilde Thye Hansen, Reidar Albrechtsen, Ulla M Wewer, Marie Kveiborg.   

Abstract

ADAM12 is an active metalloprotease playing an important role in tumour progression. Human ADAM12 exists in two splice variants: a long transmembrane form, ADAM12-L, and a secreted form, ADAM12-S. The subcellular localization of ADAM12-L is tightly regulated and involves intracellular interaction partners and signalling proteins. We demonstrate here a c-Src-dependent redistribution of ADAM12-L from perinuclear areas to actin-rich Src-positive structures at the cell periphery, and identified two separate c-Src binding sites in the cytoplasmic tail of ADAM12-L that interact with the SH3 domain of c-Src with different binding affinities. The association between ADAM12-L and c-Src is transient, but greatly stabilized when the c-Src kinase activity is disrupted. In agreement with this observation, kinase-active forms of c-Src induce ADAM12-L tyrosine phosphorylation. Interestingly, ADAM12-L was also found to enhance Src kinase activity in response to external signals, such as integrin engagement. Thus, we suggest that activated c-Src binds, phosphorylates, and redistributes ADAM12-L to specific sites at the cell periphery, which may in turn promote signalling mechanisms regulating cellular processes with importance in cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19769962     DOI: 10.1016/j.yexcr.2009.09.017

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).

Authors:  Marie Kveiborg; Jonas Jacobsen; Meng-Huee Lee; Hideaki Nagase; Ulla M Wewer; Gillian Murphy
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

2.  ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.

Authors:  Dorothee Fried; Beate B Böhm; Kristin Krause; Harald Burkhardt
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

Review 3.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

4.  Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration.

Authors:  Hélène Cousin; Genevieve Abbruzzese; Erin Kerdavid; Alban Gaultier; Dominique Alfandari
Journal:  Dev Cell       Date:  2011-02-15       Impact factor: 12.270

5.  In silico QTL mapping of basal liver iron levels in inbred mouse strains.

Authors:  Stela McLachlan; Seung-Min Lee; Teresa M Steele; Paula L Hawthorne; Matthew A Zapala; Eleazar Eskin; Nicholas J Schork; Gregory J Anderson; Chris D Vulpe
Journal:  Physiol Genomics       Date:  2010-11-09       Impact factor: 3.107

Review 6.  A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications.

Authors:  Erin K Nyren-Erickson; Justin M Jones; D K Srivastava; Sanku Mallik
Journal:  Biochim Biophys Acta       Date:  2013-05-13

7.  Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.

Authors:  Qiushi Lin; Xuesong Chen; Fanzheng Meng; Kosuke Ogawa; Min Li; Ruipeng Song; Shugeng Zhang; Ziran Zhang; Xianglu Kong; Qinggang Xu; Fuliang He; Dan Liu; Xuewei Bai; Bei Sun; Mien-Chie Hung; Lianxin Liu; Jack R Wands; Xiaoqun Dong
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

8.  Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival.

Authors:  Anthony Leyme; Katia Bourd-Boittin; Dominique Bonnier; Anaïs Falconer; Yannick Arlot-Bonnemains; Nathalie Théret
Journal:  Mol Biol Cell       Date:  2012-07-05       Impact factor: 4.138

9.  Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.

Authors:  Dorte Stautz; Ulla M Wewer; Marie Kveiborg
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

10.  Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.

Authors:  Begoña Díaz; Angela Yuen; Shinji Iizuka; Shigeki Higashiyama; Sara A Courtneidge
Journal:  J Cell Biol       Date:  2013-04-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.